AtriCure: A Company Overview
Company Leadership
Michael Carrel, President and Chief Executive Officer
Michael Carrel has been the President, Chief Executive Officer, and director of AtriCure since November 2012.
He has also served on the board of Axonics since March 4, 2019.
Under Carrel's leadership, AtriCure has been executing on the company's promise.
Financial Overview
According to the state of Ohio, AtriCure is getting an estimated $133 million in tax credits over 12 years.
Management Team
AtriCure's management team consists of proven leaders, respected innovators, and caring and compassionate individuals.
The team is committed to providing innovative solutions for patients with atrial fibrillation (AFib).
Mission Statement
AtriCure's mission is to develop, manufacture, and market innovative medical devices and technologies for the treatment of Afib.
The company is dedicated to improving the lives of patients with Afib.
Values
AtriCure's values are:
- Innovation
- Quality
- Integrity
- Collaboration
- Service
Komentar